Label Changes for:
NegGram (Nalidixic acid, USP) Caplet
November 2012
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
November 2012
ADVERSE REACTIONS
Other
- Tendon disorders including tendon rupture

